- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 51 results
Article
Juni 12, 2025
5 Open Questions About FDA's AI-Assisted Review Plans
Client Alert
Mai 19, 2025
FDA Announces Completion of AI-Assisted Scientific Review Pilot and Deployment of Agency-Wide AI-Assisted Review
Article
Mai 1, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
Client Alert
März 24, 2025
Tools of the Trade: Reacting to Government Contract Terminations and Pauses
Client Alert
März 11, 2025
EU & UK AI Round-up
Client Alert
Februar 18, 2025
Employers’ Use of Artificial Intelligence in the Workplace After President Trump’s Executive Orders
Article
Februar 18, 2025
Keeping Up-To-Date Tracking of AI-Related News from the EU and UK
Client Alert
Februar 14, 2025
Trump Administration Early Executive Orders Signal Shift in AI Policy
Client Alert
Januar 31, 2025
Full Steam Ahead: Unpacking President Trump’s Executive Orders Impacting Federal Contractors
Client Alert
Januar 30, 2025
Department of Commerce Issues Export Controls on Advanced Computing Chips and Artificial Intelligence Models
Client Alert
Januar 23, 2025
Biden Administration’s Eleventh-Hour Executive Order Imposes New Software Requirements on Companies
Client Alert
Januar 15, 2025
EU & UK AI Roundup – January 2025